XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
79 hedge funds and large institutions have $593M invested in Acceleron Pharma in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
79
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$46.9M | |
| 2 | +$28.2M | |
| 3 | +$27.6M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$9.95M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.75M |
Top Sellers
| 1 | -$8.97M | |
| 2 | -$8.62M | |
| 3 | -$2.74M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$2.59M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.53M |